IDH-WILDTYPE GLIOBLASTOMA

Clinical trials for IDH-WILDTYPE GLIOBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new IDH-WILDTYPE GLIOBLASTOMA trials appear

Sign up with your email to follow new studies for IDH-WILDTYPE GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Can a seizure drug outsmart a deadly brain tumor?

Disease control Not yet recruiting

This trial tests whether adding levetiracetam, a seizure medication, to the standard treatment for glioblastoma can improve outcomes. Glioblastoma is an aggressive brain cancer with poor survival despite current therapy. The study focuses on tumors with low oxygen levels, which a…

Matched conditions: IDH-WILDTYPE GLIOBLASTOMA

Phase: PHASE2 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

IDH-WILDTYPE GLIOBLASTOMA

Get alerted when new IDH-WILDTYPE GLIOBLASTOMA trials appear

Can a seizure drug outsmart a deadly brain tumor?